封面
市场调查报告书
商品编码
1454726

毛细血管采血设备市场-依产品类型(微容器管、微血细胞比容管、加温装置、采血装置)、应用(血糖监测、血球比容、胆固醇测试)、材料、最终用途-全球预测,2024 -2032年

Capillary Blood Collection Devices Market - By Product Type (Micro-container Tube, Micro-hematocrit Tube, Warming Device, Lancing Device), Application (Glucose Monitoring, Hematocrit, Cholesterol Testing), Material, End-use-Global Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 186 Pages | 商品交期: 2-3个工作天内

价格
简介目录

在慢性病盛行率上升、对即时检测 (POCT) 的日益重视以及家庭医疗保健扩张的推动下,毛细血管采血设备市场预计在 2024 年至 2032 年期间将以 7.7% 的速度增长。

糖尿病、心血管疾病和癌症等慢性病的发生率稳定上升,需要频繁的监测和诊断测试。据世界卫生组织称,非传染性疾病(NCD)每年夺走 4,100 万人的生命,占全球死亡人数的 74%。其中,1700万人过早死亡,其中86%集中在低收入和中等收入国家。毛细血管采血设备使医疗保健提供者能够快速有效地收集血液样本,特别是在即时检测 (POCT) 环境和家庭医疗保健环境中,从而促进诊断。随着人口老化的增长和预防性医疗保健计划的普及,对这些用于诊断测试和监测目的的设备的需求预计将增加,从而推动市场扩张。

毛细血管采血设备市场根据产品类型、应用、材料、最终用途和地区进行分类。

预计到 2032 年,加温设备领域的需求将激增,因为它们透过温和地加热目标区域来促进毛细血管血液样本的采集,从而增加血流量并最大限度地减少患者的不适。这些设备在寒冷环境中或在处理儿科或老年患者时非常有用,因为在这些情况下获取足够的血液样本可能具有挑战性。此外,加温装置有助于维持所采集样本的质量,降低凝血风险并确保准确的测试结果。

玻璃材料领域预计在 2032 年获得牵引力。玻璃具有卓越的透明度,能够对血液样本进行精确的目视检查并促进准确的分析。此外,玻璃管具有化学惰性,可防止与管材相互作用,从而确保所收集样品的完整性。这使得玻璃成为毛细血管采血装置的首选材料,特别是在样本品质至关重要的实验室环境中。

在医疗基础设施快速扩张以及慢性病盛行率上升的推动下,亚太地区毛细血管采血设备产业份额将在 2024 年至 2032 年期间扩大。中国、印度和日本等国家对医疗保健的投资不断增加,刺激了对毛细血管采血设备的需求。此外,人们对预防性医疗保健措施的认识不断增强,以及现场检测的日益普及,也有助于该地区的市场扩张。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 慢性病盛行率增加
      • 越来越重视即时侦测 (POCT)
      • 技术进步与产品创新
      • 家庭医疗保健和自我监测的兴起
    • 产业陷阱与挑战
      • 用于测试的血量有限
      • 关于疼痛和不适的担忧
  • 成长潜力分析
  • 技术景观
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按产品类型,2018 年 - 2032 年

  • 主要趋势
  • 微型容器管
  • 微量血球容积比管
  • 加温装置
  • 采血装置
    • 可调式采血装置
    • 不可调节采血装置
  • 其他产品类型

第 6 章:市场估计与预测:按材料划分,2018 - 2032 年

  • 主要趋势
  • 塑胶
  • 玻璃
  • 其他材料

第 7 章:市场估计与预测:按应用,2018 - 2032

  • 主要趋势
  • 血糖监测
  • 血球容积比测试
  • 胆固醇测试
  • 凝血测试
  • 其他应用

第 8 章:市场估计与预测:按最终用途,2018 - 2032 年

  • 主要趋势
  • 医院和诊所
  • 血库
  • 诊断中心
  • 家庭诊断
  • 其他最终用户

第 9 章:市场估计与预测:按地区划分,2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 10 章:公司简介

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Cardinal Health
  • Greiner Bio-One International GmbH
  • Medtronic plc
  • Radiometer Medical ApS
  • Roche Diagnostics
  • Sarstedt AG & Co.
  • Siemens Healthineers
  • Terumo Corporation
简介目录
Product Code: 8035

Capillary Blood Collection Devices Market is expected to grow at a rate of 7.7% during 2024-2032, driven by rising prevalence of chronic diseases, growing emphasis on point-of-care testing (POCT), and expansion of home healthcare.

The steady rise in chronic conditions such as diabetes, cardiovascular diseases, and cancer necessitates frequent monitoring and diagnostic testing. According to WHO, each year, noncommunicable diseases (NCDs) claim 41 million lives, accounting for 74% of all global deaths. Of these, 17 million occur prematurely, with 86% of these early deaths concentrated in low- and middle-income countries. Capillary blood collection devices facilitate diagnosis by enabling healthcare providers to collect blood samples quickly and efficiently, particularly in point-of-care testing (POCT) settings and home healthcare environments. As the aging population grows and preventive healthcare initiatives gain traction, the demand for these devices for diagnostic testing and monitoring purposes is expected to increase, driving market expansion.

Capillary Blood Collection Devices Market is classified based on product type, application, material, end-use, and region.

Warming device segment is expected to witness a demand surge by 2032, as they facilitate the collection of capillary blood samples by gently heating the targeted area, thereby increasing blood flow and minimizing discomfort for patients. These devices are beneficial in cold environments or when dealing with pediatric or elderly patients, where obtaining a sufficient blood sample can be challenging. Additionally, warming devices help preserve the quality of the collected sample, reducing the risk of clotting and ensuring accurate test results.

Glass material segment is poised to gain traction through 2032. Glass offers superior clarity, enabling precise visual inspection of blood samples and facilitating accurate analysis. Moreover, glass tubes are chemically inert, ensuring the integrity of the collected sample by preventing interactions with the tube material. This makes glass a preferred material for capillary blood collection devices, particularly in laboratory settings where sample quality is paramount.

Asia Pacific capillary blood collection devices industry share will enlarge over 2024 to 2032, driven by rapidly expanding healthcare infrastructure, coupled with the rising prevalence of chronic diseases. Countries such as China, India, and Japan are witnessing increased investments in healthcare, fueling the demand for capillary blood collection devices. Moreover, the growing awareness about preventive healthcare measures and the rising adoption of point-of-care testing contribute to market expansion in the region.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data validation
  • 1.6 Data sources
    • 1.6.1 Primary
    • 1.6.2 Secondary
      • 1.6.2.1 Paid sources
      • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Increasing prevalence of chronic diseases
      • 3.2.1.2 Growing emphasis on point-of-care testing (POCT)
      • 3.2.1.3 Technological advancements and product innovations
      • 3.2.1.4 Rise in home healthcare and self-monitoring
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Limited blood volume for testing
      • 3.2.2.2 Concerns regarding pain and discomfort
  • 3.3 Growth potential analysis
  • 3.4 Technological landscape
  • 3.5 Porter's analysis
    • 3.5.1 Supplier power
    • 3.5.2 Buyer power
    • 3.5.3 Threat of new entrants
    • 3.5.4 Threat of substitutes
    • 3.5.5 Industry rivalry
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Micro-container tubes
  • 5.3 Micro-hematocrit tubes
  • 5.4 Warming devices
  • 5.5 Lancing devices
    • 5.5.1 Adjustable lancing devices
    • 5.5.2 Non-adjustable lancing devices
  • 5.6 Other product types

Chapter 6 Market Estimates and Forecast, By Material, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Plastic
  • 6.3 Glass
  • 6.4 Other materials

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Glucose monitoring
  • 7.3 Hematocrit testing
  • 7.4 Cholesterol testing
  • 7.5 Coagulation testing
  • 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Hospitals and clinics
  • 8.3 Blood banks
  • 8.4 Diagnostic centers
  • 8.5 Home diagnosis
  • 8.6 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Italy
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 Abbott Laboratories
  • 10.2 Becton, Dickinson and Company
  • 10.3 Cardinal Health
  • 10.4 Greiner Bio-One International GmbH
  • 10.5 Medtronic plc
  • 10.6 Radiometer Medical ApS
  • 10.7 Roche Diagnostics
  • 10.8 Sarstedt AG & Co.
  • 10.9 Siemens Healthineers
  • 10.10 Terumo Corporation